Tim Pearson, Carrick Therapeutics CEO
Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment
In a big week for Carrick Therapeutics, the company announced $60 million in funding for its lead breast cancer drug and development of a second …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
